Author Archives: 8sjs5

The New (Improved..?) Roles of Drugs

Greenslit’s article raises interesting questions about the ways both institutions and individuals appropriate drugs for their own use and to achieve a variety of ends. In their growing new role as consumer products, it seems to some extent unavoidable that … Continue reading

Posted in Uncategorized | Leave a comment

What Constitutes ‘Genuine’ Consent?

This week’s articles demonstrate the shortcomings present in clinical trials’ practices of recruiting and informing their human subjects. Fisher proposes that the commonly accepted ‘informed consent’ standard is one of the most important of these shortcomings, using case studies to … Continue reading

Posted in Uncategorized | 1 Comment

Further Ethical Issues in R&D

                Petryna’s article discusses some further ethical issues which exist within the clinical trial phase of drugs’ development, focusing on CROs heavy recruitment of ‘offshore’ subjects for these trials. She shows that there exist … Continue reading

Posted in Uncategorized | 1 Comment

Everything in Moderation

Grossman and MacKenzie’s article suggests the need for a change in the reputation of randomized controlled trials as the most effective and reliable form of study. Its appearance as superior has resulted in a highly prevalent desire amongst researchers to … Continue reading

Posted in Uncategorized | Leave a comment

Big Pharma’s Power: Making Everyone Work for Them

This week’s articles discuss some of the methods used by the pharmaceutical industry to render the goals and actions of other influential actors in the R&D process (members of the ‘distribution channel’) compatible with their own. Since physicians, patients, and … Continue reading

Posted in Uncategorized | Leave a comment

Accepting the Side Effects of Separating Research and Industry

Sismondo suggests that a total severing of the relationships between the pharmaceutical industry and medical research is the most complete solution to the problem of bias within the system of research, trials and publication on drugs. Such a separation between … Continue reading

Posted in Uncategorized | Leave a comment

Week 6 Summary of Readings

This week’s three articles continue our investigation of the effects that marketing and pressure from the sales-driven pharmaceutical sector have upon healthcare and physicians’ abilities to attend to their ‘primary duties’ of providing patient care. Each provides a closer investigation … Continue reading

Posted in Uncategorized | Leave a comment